Skip to main content
. Author manuscript; available in PMC: 2015 Sep 18.
Published in final edited form as: Bone Marrow Transplant. 2015 May 11;50(9):1173–1179. doi: 10.1038/bmt.2015.103

Figure 3.

Figure 3

Figure 3

Figure 3

The effect of post-HCT MRD positivity on event free survival (EFS) when tested at specific time points after transplant. a) EFS from day +55 by post-engraftment MRD status. At day +55 patients on study n=131, patients with MRD assessment prior to day +55 (planned day +30, range day 18–54) n=95, MRD negative n=88, MRD positive n=7. b) EFS from day +200 by three month MRD status. At day +200 patients on study n=131, patients with MRD assessment between day +55 and day +200 (planned day +100, range day 76–181) n=95, MRD negative n=88, MRD positive n=7. c) EFS from day +300 by eight month MRD status. At day +300 patients on study n=93, patients with MRD assessment between day +200 and day +300 (optional assessment day +240, range day 226–290) n=37, MRD negative n=31, MRD positive n=6.